Hilo

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Hilo is a healthcare company that provides blood pressure, digital therapeutics, and patient management services.

HQ Location

Neuchâtel (Switzerland)

Founded

2018

Employees

51 - 200

Total funding raised

$101.68M

Funding Status

Series B, $42.00M, May 1, 2025

Aktiia, now trading under Hilo, was established in 2018 to transform how blood pressure is measured and therefore managed.



Hilo is transforming blood pressure monitoring with cuffless, AI-powered technology that delivers continuous, accessible insights for individuals and healthcare professionals. Our foundation model is trained on billions of optical signals and hundreds of millions of readings from over 120,000 users—one of the largest datasets in the field. Backed by a multidisciplinary team with deep expertise in biomedical signal processing, Hilo has contributed to over 120 peer-reviewed publications and holds more than 35 patents. Headquartered in Switzerland, we’re expanding globally to redefine how blood pressure is measured and managed.